XML 82 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Private Placement
Private Placement
Common Stock
Private Placement
Additional Paid In Capital
IPO
IPO
Common Stock
IPO
Additional Paid In Capital
Series Seed Convertible Preferred Stock
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series B-1 Convertible Preferred
Series C Convertible Preferred Stock
Temporary Equity, Beginning Balance at Dec. 31, 2018                       $ 5,900 $ 28,794 $ 38,735    
Temporary Equity, Beginning Balance, Shares at Dec. 31, 2018                       3,000,000 14,498,547 9,605,905    
Beginning Balance at Dec. 31, 2018 $ (34,436)   $ 774 $ (35,210)                        
Beginning Balance at Dec. 31, 2018   1,479,188                            
Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5)                         $ 443      
Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5), Shares                         221,579      
Issuance of Preferred Stock, net of issuance costs                           $ 21,183 $ 14,025  
Issuance of Series B-1 Preferred Stock, net of issuance costs of $49, Shares                           5,221,675 3,059,695  
Exercise of Stock Options 74   74                          
Exercise of Stock Options, Shares   95,904                            
Vesting Restricted Stock, Shares   354,424                            
Stock-based compensation expense 1,196   1,196                          
Unrealized gain on marketable securities 6       $ 6                      
Net Loss (41,246)     (41,246)                        
Temporary Equity, Ending Balance at Dec. 31, 2019                       $ 5,900 $ 29,237 $ 59,918 $ 14,025  
Temporary Equity, Ending Balance, Shares at Dec. 31, 2019                       3,000,000 14,720,126 14,827,580 3,059,695  
Ending Balance at Dec. 31, 2019 (74,406)   2,044 (76,456) 6                      
Ending Balance, Shares at Dec. 31, 2019   1,929,516                            
Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5)                         $ 222      
Vesting of Series A Preferred Stock in connection with collaboration arrangement (Note 5), Shares                         110,788      
Issuance of Preferred Stock, net of issuance costs                           $ 4,800   $ 88,180
Issuance of Series B-1 Preferred Stock, net of issuance costs of $49, Shares                           1,182,265   13,539,141
Temporary Equity, Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock                         $ (3,950)     $ 13,000
Temporary Equity, Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock, Shares                         (1,988,802)     1,988,802
Exchange of Series A Convertible Preferred Stock for Series C Preferred Convertible Preferred Stock (9,050)   (2,334) (6,716)                        
Exercise of Stock Options 162   162                          
Exercise of Stock Options, Shares   78,852                            
Vesting Restricted Stock 112   112                          
Vesting Restricted Stock, Shares   184,410                            
Stock-based compensation expense 5,190   5,190                          
Unrealized gain on marketable securities (134)       (134)                      
Issuance of shares           $ 13,527   $ 13,527 $ 182,748 $ 1 $ 182,747          
Issuance of shares, Shares             676,354     9,987,520            
Conversion of convertible preferred stock into common stock 211,332 $ 3 211,329                 $ (5,900) $ (25,509) $ (64,718) $ (14,025) $ (101,180)
Conversion of convertible preferred stock into common, Shares   31,625,534                   (3,000,000) (12,842,112) (16,009,845) (3,059,695) (15,527,943)
Net Loss (45,593)     (45,593)                        
Ending Balance at Dec. 31, 2020 283,888 $ 4 412,777 (128,765) (128)                      
Ending Balance, Shares at Dec. 31, 2020   44,482,186                            
Exercise of Stock Options 7,633 $ 1 7,632                          
Exercise of Stock Options, Shares   1,431,271                            
Vesting Restricted Stock, Shares   72,359                            
Stock-based compensation expense 24,972   24,972                          
Unrealized gain on marketable securities (532)       (532)                      
Issuance of shares           $ 2,346   $ 2,346 $ 240,760   $ 240,760          
Issuance of shares, Shares             49,928     5,468,250            
Net Loss (100,217)     (100,217)                        
Issuance of shares under employee stock purchase plan, Value 788   788                          
Issuance of shares under employee stock purchase plan, Share   19,687                            
Issuance of vested restricted stock to consultants, Share   12,500                            
Ending Balance at Dec. 31, 2021 $ 459,638 $ 5 $ 689,275 $ (228,982) $ (660)                      
Ending Balance, Shares at Dec. 31, 2021   51,536,181